Many people associate dopamine with reward or attention. Some might think of the part it plays in ad
Read More
BerGenBio has posted updated data from its phase 2 trial of bemcentinib in acute myeloid leukaemia (
Read More
Antifungal specialist Scynexis has nabbed Nkechi Azie, M.D., as its vice president of clinical devel
Read More
Gene therapy specialist uniQure is considering selling up amid interest from large pharma buyers, ac
Read More
Johnson & Johnson’s Ethicon unit has received a 510(k) clearance from the FDA for its Vistaseal appl
Read More
Bio-Techne’s urine test, designed to track down the exosomes and genomic markers released from prost
Read More
The green light from the US regulator is for a regimen based on BTK inhibitor Imbruvica (ibrutinib)
Read More